Literature DB >> 19945922

High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma.

Xiaoqiang Xiang1, Yi Han, Mikko Neuvonen, Jouko Laitila, Pertti J Neuvonen, Mikko Niemi.   

Abstract

We report a sensitive and robust method to determine cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA), ursodeoxycholic acid (UDCA), and their taurine- and glycine-conjugate concentrations in human plasma using liquid chromatography-tandem mass spectrometry. Activated charcoal was utilized to prepare bile acid-free plasma, which served as the biological matrix for the preparation of standard and quality control samples. Plasma sample preparation involved solid-phase extraction. A total of 16 bile acids and 5 internal standards were separated on a reverse column by gradient elution and detected by tandem mass spectrometry in negative ion mode. The calibration curve was linear for all the bile acids over a range of 0.005-5micromol/L. The extraction recoveries for all the analytes fell in the range of 88-101%. Intra-day and inter-day coefficients of variation were all below 10%. A stability test showed that all the bile acids were stable in plasma for at least 6h at room temperature, at least three freeze-thaw cycles, in the -70 degrees C or -20 degrees C freezer for 2 months, and also in the reconstitution solution at 8 degrees C for 48h. Comparison of the matrix effect of bile acid-free plasma with that of real plasma indicated that the charcoal purification procedure did not affect the properties of charcoal-purified plasma as calibration matrix. This method has been used to determine the bile acid concentrations in more than 300 plasma samples from healthy individuals. In conclusion, this method is suitable for the simultaneous quantification of individual bile acids in human plasma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19945922     DOI: 10.1016/j.jchromb.2009.11.019

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  18 in total

1.  Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump.

Authors:  Dongfang Yang; Jian Yang; Deshi Shi; Da Xiao; Yi-Tzai Chen; Chris Black; Ruitang Deng; Bingfang Yan
Journal:  J Lipid Res       Date:  2012-01-14       Impact factor: 5.922

2.  Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.

Authors:  Juan C García-Cañaveras; M Teresa Donato; José V Castell; Agustín Lahoz
Journal:  J Lipid Res       Date:  2012-07-19       Impact factor: 5.922

3.  No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.

Authors:  Xiaoqiang Xiang; Juha Vakkilainen; Janne T Backman; Pertti J Neuvonen; Mikko Niemi
Journal:  Eur J Clin Pharmacol       Date:  2011-06-08       Impact factor: 2.953

4.  Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study.

Authors:  Tilman Kühn; Magdalena Stepien; Marina López-Nogueroles; Antje Damms-Machado; Disorn Sookthai; Theron Johnson; Marta Roca; Anika Hüsing; Sandra González Maldonado; Amanda J Cross; Neil Murphy; Heinz Freisling; Sabina Rinaldi; Augustin Scalbert; Veronika Fedirko; Gianluca Severi; Marie-Christine Boutron-Ruault; Francesca Romana Mancini; Solomon A Sowah; Heiner Boeing; Paula Jakszyn; Maria J Sánchez; Susana Merino; Sandra Colorado-Yohar; Aurelio Barricarte; Kay Tee Khaw; Julie A Schmidt; Aurora Perez-Cornago; Antonia Trichopoulou; Anna Karakatsani; Paschalis Thriskos; Domenico Palli; Claudia Agnoli; Rosario Tumino; Carlotta Sacerdote; Salvatore Panico; Bas Bueno-de-Mesquita; Carla H van Gils; Alicia K Heath; Marc J Gunter; Elio Riboli; Agustín Lahoz; Mazda Jenab; Rudolf Kaaks
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

5.  Effect of bile duct ligation on bile acid composition in mouse serum and liver.

Authors:  Youcai Zhang; Ji-Young Hong; Cheryl E Rockwell; Bryan L Copple; Hartmut Jaeschke; Curtis D Klaassen
Journal:  Liver Int       Date:  2011-10-17       Impact factor: 5.828

6.  Simple and rapid quantitation of 21 bile acids in rat serum and liver by UPLC-MS-MS: effect of high fat diet on glycine conjugates of rat bile acids.

Authors:  Yudai Suzuki; Rina Kaneko; Mina Nomura; Hisao Naito; Kazuya Kitamori; Tamie Nakajima; Tadashi Ogawa; Hideki Hattori; Hiroshi Seno; Akira Ishii
Journal:  Nagoya J Med Sci       Date:  2013-02       Impact factor: 1.131

7.  Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate.

Authors:  J Trottier; P Caron; R J Straka; O Barbier
Journal:  Clin Pharmacol Ther       Date:  2011-06-29       Impact factor: 6.875

8.  Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents.

Authors:  Andrea Mencarelli; Barbara Renga; Claudio D'Amore; Chiara Santorelli; Luigina Graziosi; Angela Bruno; Maria Chiara Monti; Eleonora Distrutti; Sabrina Cipriani; Annibale Donini; Stefano Fiorucci
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

9.  Analysis of the serum bile Acid composition for differential diagnosis in patients with liver disease.

Authors:  Tomonori Sugita; Katsushi Amano; Masanori Nakano; Noriko Masubuchi; Masahiro Sugihara; Tomokazu Matsuura
Journal:  Gastroenterol Res Pract       Date:  2015-03-03       Impact factor: 2.260

10.  Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability.

Authors:  Delilah F G Hendriks; Lisa Fredriksson Puigvert; Simon Messner; Wolfgang Mortiz; Magnus Ingelman-Sundberg
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.